Peddock Capital Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Peddock Capital Advisors's BSX Position: Q2 2026 in Review
Peddock Capital Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 4,080 shares — an estimated $256K sold.
Peddock Capital Advisors first reported a position in BSX in Q2 2017 and held it in 28 quarters. The position peaked at $449K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Peddock Capital Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
- Peddock Capital Advisors sold 4,080 Boston Scientific shares in Q2 2026, an estimated $256K.
- Peddock Capital Advisors first reported a position in Boston Scientific in Q2 2017 and held it in 28 quarters.
- Peddock Capital Advisors's Boston Scientific position peaked at $449K in Q2 2025.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Peddock Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.